Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q1 EPS of ($0.37), $0.02 worse than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Repros Therapeutics, Inc. (RPRX) click here.